A 19-year-old male presents with a 4-month history of progressive nasal obstruction, recurrent epistaxis requiring blood transfusion, and facial pain. Endoscopy reveals a large, bleeding mass in the nasopharynx. CT imaging shows a heterogeneously enhancing mass with widening of the pterygopalatine fossa and erosion of the pterygoid plates. The patient is scheduled for endoscopic resection. What is the most appropriate preoperative intervention to reduce intraoperative hemorrhage?

Explanation

## Preoperative Management of Nasopharyngeal Angiofibroma ### The Problem: Hemorrhage Risk **Key Point:** Nasopharyngeal angiofibroma is a highly vascular tumor with blood supply primarily from the **maxillary artery** (branch of external carotid). Intraoperative hemorrhage can be catastrophic if the tumor is resected without vascular control. **High-Yield:** Preoperative angiography with embolization is the **gold standard** for reducing operative blood loss and improving surgical outcomes in NAF. ### Preoperative Angiography with Embolization #### Mechanism 1. **Diagnostic angiography:** Identifies the feeding vessels (usually maxillary artery and its branches) 2. **Embolization:** Injection of embolic material (polyvinyl alcohol particles, microcoils, or glue) into the feeding arteries to occlude blood supply 3. **Timing:** Performed 24–48 hours before surgery to allow collateral circulation to stabilize and reduce tumor bleeding during resection #### Benefits | Benefit | Impact | |---------|--------| | **Reduced intraoperative hemorrhage** | Decreases blood loss by 50–80% | | **Improved visualization** | Surgeon can see the tumor better | | **Shorter operative time** | Less time spent controlling bleeding | | **Lower transfusion requirements** | Reduces morbidity from transfusion | | **Better surgical outcomes** | Complete resection more likely | ### Why Other Options Are Incorrect **Warning:** Systemic corticosteroids do NOT reduce tumor vascularity in NAF. While steroids may reduce mucosal edema, they do not address the fundamental vascular anatomy of the tumor and will not prevent intraoperative hemorrhage. **Clinical Pearl:** Immediate endoscopic resection without angiography is dangerous and contraindicated. NAF is so vascular that uncontrolled resection can lead to life-threatening hemorrhage, airway compromise, and the need for emergency external carotid ligation. **High-Yield:** Radiation therapy is NOT first-line treatment for NAF. While NAF is radiosensitive and may shrink with radiation, surgery (preferably endoscopic) is the definitive treatment. Radiation is reserved for: - Recurrent tumors after failed surgical resection - Tumors with intracranial extension - Patients who refuse surgery Radiation does not eliminate the need for preoperative embolization if surgery is planned. ### Complete Preoperative Workup for NAF ```mermaid flowchart TD A[Suspected NAF on endoscopy]:::outcome --> B[CT/MRI for staging]:::action B --> C{Assess extent}:::decision C -->|Local disease| D[Angiography]:::action C -->|Intracranial extension| E[MRI with contrast]:::action D --> F[Embolization 24-48 hrs before surgery]:::action E --> G{Resectable?}:::decision F --> H[Endoscopic resection]:::action G -->|Yes| H G -->|No| I[Neoadjuvant radiation]:::action H --> J[Histopathology confirmation]:::outcome J --> K[Follow-up endoscopy at 3, 6, 12 months]:::action ``` ### Staging and Prognosis **Fisch Classification** (commonly used): - **Stage I:** Confined to nasopharynx - **Stage II:** Extends into maxillary sinus and/or nasal cavity - **Stage III:** Extends into infratemporal fossa or pterygopalatine fossa - **Stage IV:** Intracranial extension **Recurrence rate:** 10–30% (higher with incomplete resection or intracranial extension) [cite:Dhingra 7e Ch 6; Cummings Otolaryngology 6e Ch 42]